Literature DB >> 6161678

The PO glycoprotein of peripheral nerve myelin.

A Ishaque, M W Roomi, I Szymanska, S Kowalski, E H Eylar.   

Abstract

The PO glycoprotein, the major protein of peripheral nerve myelin, is a hydrophobic glycoprotein which can be isolated in soluble and insoluble forms from rabbit sciatic nerve myelin following extensive defatting and mid acidic extraction. The PO glycoprotein was localized exclusively in peripheral nervous system (PNS) myelin of sciatic nerve and rootlets by the immunofluorescent technique using goat anti-PO serum which showed a single precipitin band in double diffusion and did not cross-react with the myelin basic protein or P2 protein. Central nervous system (CNS) myelin from brain and spinal cord was negative by the immunofluorescent procedure. The major glycoprotein bands in PNS myelin, in addition to the PO glycoprotein at 28K, exist at 23K and 19K, as shown by gel electrophoresis in dodecyl sulfate. These glycoproteins, isolated by gel filtration in 2% dodecyl sulfate, show identity to the PO glycoprotein in their monosaccharide profile and overlapping tryptic peptides on peptide mapping. We conclude that both the 23K and 19K glycoproteins are derived from the PO glycoprotein by in situ proteolysis; the 23K glycoprotein has the identical amino terminal sequence. The 19K glycoprotein, beginning with amino-terminal methionine, is identical with the TPO glycoprotein, shown previously to originate from tryptic hydrolysis of the PO glycoprotein in isolated myelin. A tryptic glycopeptide containing 27 amino acids was isolated from the PO glycoprotein and sequenced. It contained a relatively high proportion of aspartic acid (four residues) and glutamic acid (two residues), thus exhibiting a high negative charge. We conclude that the total carbohydrate of the PO, 23K, and 19K glycoproteins does indeed exist as a single nonasaccharide moiety linked through N-acetylglucosamine to Asp-14 of the glycopeptide in a N-glycosidic linkage. These results further support the role of the PO glycoprotein as a typical amphipathic membrane protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6161678     DOI: 10.1139/o80-125

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  18 in total

Review 1.  Neuroactive steroids: A therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events.

Authors:  Emanuela Leonelli; Marinella Ballabio; Antonio Consoli; Ilaria Roglio; Valerio Magnaghi; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 2.  Myelin P0: new knowledge and new roles.

Authors:  Joseph Eichberg
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

3.  Infantile neuropathy with unstable myelin: study of the P0 protein.

Authors:  S Peudenier; J F Deleuze; D Pham-Dinh; C Lacroix; J Boulloche; P Landrieu
Journal:  J Neurol       Date:  1993-05       Impact factor: 4.849

4.  Distribution of concanavalin A and wheat germ agglutinin binding sites in the rat peripheral nerve fibres revealed by lectin/glycoprotein-gold histochemistry.

Authors:  S Dolapchieva
Journal:  Histochem J       Date:  1996-01

5.  Tumor promoters accentuate phosphorylation of PO: evidence for the presence of protein kinase C in purified PNS myelin.

Authors:  H C Agrawal; D Agrawal
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

6.  Association and release of the major intrinsic membrane glycoprotein from peripheral nerve myelin.

Authors:  J F Poduslo; J K Yao
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

7.  Membrane interactions in nerve myelin: II. Determination of surface charge from biochemical data.

Authors:  H Inouye; D A Kirschner
Journal:  Biophys J       Date:  1988-02       Impact factor: 4.033

8.  Cyclic AMP-stimulated protein kinase activity in rabbit peripheral myelin.

Authors:  V Zabrenetzky; V Krygier-Brévart; P S Spencer
Journal:  Neurochem Res       Date:  1984-01       Impact factor: 3.996

9.  Induced reciprocal translocation in transgenic mice near sites of transgene integration.

Authors:  U Francke; C L Hsieh; D Kelly; E Lai; B Popko
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

10.  Monoclonal antibody specific for myelin glycoprotein P0: derivation and characterization.

Authors:  M C Franko; C L Koski; C J Gibbs; D E McFarlin; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.